Startups
Advancing Non-Systemic Medicines for Inflammatory Skin Diseases Turn Therapeutics develops first-in-class topical therapies that act within the skin to prevent unnecessary immune activation without systemic exposure or injections. Explore GX-03 Explore Pipeline Turn Therapeutics is a clinical-stage biotechnology company advancing first-in-class therapies designed to act where disease occurs, not where it does not. Our approach […]
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 20, 2025 | Biotech Firm Turn Therapeutics Goes Public Need for better wound care Focus on raising funds Minimal revenue and operating losses | |
| Turn Therapeutics | “Turn Therapeutics is a pharmaceutical and medical device company focused on advanced wound and dermatologic care using proprietary technology.” |
Reviews 0
FAQ about Turn Therapeutics
What has the press written about Turn Therapeutics?
Parsers VC has collected 3 articles mentioning Turn Therapeutics, among them “Biotech Firm Turn Therapeutics Goes Public Need for better wound care Focus on raising funds Minimal revenue and operating losses” (Oct 20, 2025) and “Turn Therapeutics”.
Is Turn Therapeutics still active?
Yes, Turn Therapeutics is active; its latest activity on Parsers VC dates from Aug 25, 2026.